Skip to content
10-K

Annual Report

60 DEGREES PHARMACEUTICALS, INC. SXTP SXTPW

0001554855-26-000467

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 2.64M sh
Shares Diluted FY 2025 · Dec 31, 2025 670.21K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 113.67K sh
Capex FY 2025 · Dec 31, 2025 $139.88K
Capex FY 2025 · Dec 31, 2024 $103.77K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.85M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$5.65M
Long Term Debt FY 2025 · Dec 31, 2025 $144K
Long Term Debt FY 2025 · Dec 31, 2024 $147.12K
Short Term Investments FY 2025 · Dec 31, 2025 $1.24M
Short Term Investments FY 2025 · Dec 31, 2024 $1.73M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.51M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.46M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.04M
Current Liabilities FY 2025 · Dec 31, 2025 $1.84M
Current Liabilities FY 2025 · Dec 31, 2024 $1.66M
Total Liabilities FY 2025 · Dec 31, 2025 $1.99M
Total Liabilities FY 2025 · Dec 31, 2024 $1.8M
Current Assets FY 2025 · Dec 31, 2025 $4.9M
Current Assets FY 2025 · Dec 31, 2024 $5.39M
Total Assets FY 2025 · Dec 31, 2025 $5.37M
Total Assets FY 2025 · Dec 31, 2024 $5.76M
Eps Diluted FY 2025 · Dec 31, 2025 −$11.73
Eps Diluted restated FY 2025 · Dec 31, 2024 −$74.17
Eps Basic FY 2025 · Dec 31, 2025 −$11.73
Eps Basic restated FY 2025 · Dec 31, 2024 −$74.17
Sga Expense FY 2025 · Dec 31, 2025 $6.28M
Sga Expense restated FY 2025 · Dec 31, 2024 $5.03M
Rd Expense FY 2025 · Dec 31, 2025 $2.11M
Rd Expense FY 2025 · Dec 31, 2024 $4.99M
Net Income FY 2025 · Dec 31, 2025 −$7.37M
Net Income FY 2025 · Dec 31, 2024 −$7.95M
Operating Income FY 2025 · Dec 31, 2025 −$7.76M
Operating Income restated FY 2025 · Dec 31, 2024 −$9.72M
Gross Profit FY 2025 · Dec 31, 2025 $223.78K
Gross Profit FY 2025 · Dec 31, 2024 $222.81K
Cost Of Revenue FY 2025 · Dec 31, 2025 $781.7K
Cost Of Revenue FY 2025 · Dec 31, 2024 $384.77K
Revenue FY 2025 · Dec 31, 2025 $1.01M
Revenue FY 2025 · Dec 31, 2024 $607.57K